|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.088 EUR | -1.16% |
|
+3.76% | -38.99% |
| 07-24 | Adocia provides a second-quarter update, Stifel still rates it a buy |  |
| 07-23 | Adocia SA Reports Unaudited Revenue Results for Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADOCIA | Bio Therapeutic Drugs | -1.16% | +3.76% | -38.99% | -39.35% | -55.08% | 93.55M |  |  | |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
